References
1. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium, 2021. URL: https://www.diabetesatlas.org
2. Mustafina S.V., Rymar O.D., Malyutina S.K., Denisova D.V., Shcherbakova L.V., Voevoda M.I. Prevalence of diabetes in the adult population of Novosibirsk. Sakharniy diabet [Diabetes Mellitus]. 2017; 20 (5): 329–34. DOI: https://doi.org/10.14341/DM8744 (in Russian)
3. Rawshani A., Rawshani A., Franzén S., Sattar N., Eliasson B., Svensson A.M., et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018; 379 (7): 633–44. DOI: https://doi.org/10.1056/NEJMoa1800256
4. Rawshani A., Franzen S., Eliasson B., et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017; 376 (15): 1407–18. DOI: https://doi.org/10.1056/NEJMoa1608664
5. Rymar O.D., Shcherbakova L.V., Shchetinina A.O., Mustafina S.V., Simonova G.I., Bakhareva Yu.S., et al. Diabetes type 2: conventional, social and some genetic predictors of cardiovascular death. Ateroskleroz [Atherosclerosis]. 2021; 17 (2): 39–50. DOI: https://doi.org/10.52727/2078-256X-2021-17-2-39-50 (in Russian)
6. Davies M.J., Drexel H., Jornayvaz F.R., Pataky Z., Seferović P.M., Wanner C. Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes. Cardiovasc Diabetol. 2022; 21 (1): 144. DOI: https://doi.org/10.1186/s12933-022-01575-9
7. Peasey A., Bobak M., Kubinova R., et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health. 2006; 18 (6): 255–65. DOI: https://doi.org/10.1186/1471-2458-6-255
8. Stevens R.J., Kothari V., Adler A.I., et al. The UKPDS Risk Engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2002; 102 (6): 679.
9. D’Agostino R.B., Sr Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117 (6): 743–53. DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.699579
10. Cavender M.A., Steg P.G., Smith S.C. Jr, et al. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circulation. 2015; 132 (10): 923–31. DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.014796
11. Algorithms for specialized medical care for patients with diabetes mellitus. In: I.I. Dedov, M.V. Shestakova, A. Yu. Mayorov (eds). 11th issue. Moscow, 2023. DOI: https://doi.org/10.14341/DM13042 (in Russian)
12. Kornienko E.A., Oynotkinova O. Sh., Baranov A.P., Goncharova E.I., Ivanov D.V. Modern views on the etiopathogenesis of myocardial infarction in diabetes mellitus type 2 and methods of treatment (literature review). Vestnik novykh meditsinskikh tekhnologiy [Bulletin of New Medical Technologies]. 2015; 2: (3-8). URL: URL: http://www.medtsu.tula.ru/VNMT/Bulletin/E2015-2/5198.pdf DOI: https://doi.org/10.12737/11912 (in Russian)
13. Yu J.M., Chen W.M., Shia B.C., Wu S.Y. Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study. Eur J Clin Pharmacol. 2023; 79 (5): 687–700. DOI: https://doi.org/10.1007/s00228-023-03488-2
14. Wang J., Chen Y., Xu W., et al. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: a meta-analysis. PLoS One. 2019; 14 (4): e0215362.
15. Malyutina S., Mazurenko E., Mazdorova E., Shapkina M., Avdeeva E., Mustafina S., et al. The profile of glucose lowering therapy in persons with type 2 diabetes mellitus in an aging Russian population. J Pers Med. 2022; 12 (10): E 1689. DOI: https://doi.org/10.3390/jpm12010122
16. Malyutina S.K., Mazdorova E.V., Shapkina M. Yu., Avdeeva E.M., Simonova G.I., Hubachek Ya.A., et al. The frequency and profile of drug treatment in subjects with dyslipidemias and cardimetabolic diseases in an urban Russian population older then 55 years. Kardiologiya [Cardiology]. 2021; 61 (12): 49–58. DOI: https://doi.org/10.18087/cardio.2021.12.n1558 (in Russian)